trial

Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES)

NCTId NCT04143126
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 90 (estimated)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2027-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
90 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2019-10-01
Primary completion
2027-06-30
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Cognitive Enhancement TherapyEnriched Supportive Therapy

Sponsors

University of Pittsburgh Medical CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

1 total
Pittsburgh, United States

Facts & assertions

4 sourced
Enrollment
90
Phase
NA
Primary Completion Date
2027-06-30
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Cognitive Enhancement Therapy
drug
Enriched Supportive Therapy
drug
lead_sponsor
University of Pittsburgh Medical Center
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication